# Omega Healthcare Investors Inc: overview

OHI · NYSE · CIK 888491 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ohi.md) · [Financials](/companies/ohi/financials.md) · [Filings](/companies/ohi/filings.md) · [Insiders](/companies/ohi/insiders.md)

Latest reported revenue: [$14.0m](/filings/0000888491-26-000024.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Jul 30, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0000888491-26-000024).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [276](/filings/0000888491-25-000040.md) | [279 d](/filings/0000888491-26-000008.md) | [277](/filings/0000888491-26-000018.md) | [283](/filings/0000888491-26-000024.md) | [312](/filings/0000888491-25-000040.md) | [319 d](/filings/0000888491-26-000008.md) | [6.7](/filings/0000888491-26-000018.md) | [14.0](/filings/0000888491-26-000024.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | [99.6%](/filings/0000888491-26-000024.md) | not reported | not reported | not reported | [2365.9%](/filings/0000888491-26-000024.md) |
| Net margin | % | [40.5%](/filings/0000888491-25-000040.md) | [40.6% d](/filings/0000888491-26-000008.md) | [39.4%](/filings/0000888491-26-000018.md) | [48.4%](/filings/0000888491-26-000024.md) | [57.7%](/filings/0000888491-25-000040.md) | [51.6% d](/filings/0000888491-26-000008.md) | [2269.0%](/filings/0000888491-26-000018.md) | [2594.0%](/filings/0000888491-26-000024.md) |
| Diluted EPS | $ per share | [0.42](/filings/0000888491-25-000040.md) | not reported | [0.33](/filings/0000888491-26-000018.md) | [0.46](/filings/0000888491-26-000024.md) | [0.59](/filings/0000888491-25-000040.md) | not reported | [0.47](/filings/0000888491-26-000018.md) | [1.19](/filings/0000888491-26-000024.md) |
| Free cash flow | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues; Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,063](/filings/0000888491-24-000007.md) | [878](/filings/0000888491-25-000006.md) | [950](/filings/0000888491-26-000008.md) | [1,051](/filings/0000888491-26-000008.md) | [1,190](/filings/0000888491-26-000008.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [40.3%](/filings/0000888491-24-000007.md) | [50.0%](/filings/0000888491-25-000006.md) | [25.5%](/filings/0000888491-26-000008.md) | [38.6%](/filings/0000888491-26-000008.md) | [49.6%](/filings/0000888491-26-000008.md) |
| Diluted EPS | $ per share | [1.75](/filings/0000888491-24-000007.md) | [1.80](/filings/0000888491-25-000006.md) | [1.00](/filings/0000888491-26-000008.md) | [1.55](/filings/0000888491-26-000008.md) | [1.94](/filings/0000888491-26-000008.md) |
| Free cash flow | $m | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:ProfitLoss; Revenue: us-gaap:Revenues; Net income: us-gaap:NetIncomeLoss.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/ohi/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $1.84bn | 38,551,916 |  | Added +1,350,553 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $1.30bn | 27,229,625 |  | Added +106,508 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $692.7m | 14,527,955 |  | Reduced −45,358 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $640.7m | 13,436,631 |  | Added +202,510 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $435.9m | 9,141,024 |  | Added +212,917 |
| [Invesco Ltd.](/funds/914208.md) | 2026-06-30 | $280.8m | 5,889,795 |  | Reduced −33,242 |
| [Bank of New York Mellon Corp](/funds/1390777.md) | 2026-06-30 | $275.2m | 5,772,439 |  | Added +1,478,627 |
| [CHARLES SCHWAB INVESTMENT MANAGEMENT INC](/funds/884546.md) | 2026-06-30 | $229.7m | 4,818,440 |  | Added +201,768 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $210.7m | 4,418,159 |  | Reduced −4,961 |
| [NORGES BANK](/funds/1374170.md) | 2026-06-30 | $190.2m | 3,989,606 |  | New +3,989,606 |

## Recent filings

[All 1,554 filings](/companies/ohi/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-05 | 06:02 ET | [8-K](/filings/0001104659-26-113450.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-113450 |
| 2026-10-01 | 08:20 ET | [8-K](/filings/0001104659-26-112589.md) | 5.02 Departure or appointment of officers or directors | 0001104659-26-112589 |
| 2026-07-30 | 11:13 ET | [10-Q](/filings/0000888491-26-000024.md) | Quarterly report, period 2026-06-30 | 0000888491-26-000024 |
| 2026-07-29 | 16:17 ET | [8-K](/filings/0000888491-26-000022.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000888491-26-000022 |
| 2026-06-05 | 16:15 ET | [8-K](/filings/0001104659-26-070979.md) | 5.07 Shareholder vote results; 8.01 Other events | 0001104659-26-070979 |
| 2026-05-21 | 16:16 ET | [8-K](/filings/0001104659-26-065158.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-065158 |
| 2026-04-29 | 11:02 ET | [10-Q](/filings/0000888491-26-000018.md) | Quarterly report, period 2026-03-31 | 0000888491-26-000018 |
| 2026-04-28 | 16:18 ET | [8-K](/filings/0000888491-26-000016.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000888491-26-000016 |
| 2026-04-21 | 08:31 ET | [DEF 14A](/filings/0001104659-26-045753.md) | Proxy statement, period 2026-06-05 | 0001104659-26-045753 |
| 2026-02-09 | 10:58 ET | [10-K](/filings/0000888491-26-000008.md) | Annual report, period 2025-12-31 | 0000888491-26-000008 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0000888491-26-000008.md), filed Feb 9, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/1d206a8e-66d0-4b16-b94a-85aae7d527c8)

## About the filer

- CIK: 888491
- Tickers: OHI
- Exchange: NYSE
- SIC code: 6798 Real Estate Investment Trusts
- State of incorporation: MD
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 27, 2026, 16:15 ET. No prices; not investment advice.